{"id":"W65908905","doi":"10.1177/1756283x10373176","title":"Review: Anti-adhesion molecule therapy for inflammatory bowel disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Natalizumab; Inflammatory bowel disease; Inflammation; Vedolizumab; Tumor necrosis factor alpha; Immunology; Cell adhesion molecule; Crohn's disease; Disease; Integrin; Monoclonal antibody; Cancer research; Antibody; Internal medicine; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005370119,0.001026296,0.001417409,0.00185728,0.0003419476,0.00143668,0.001121991,0.001927262,0.007281153],"category_scores_gemma":[0.001249917,0.0002106536,0.0006082281,0.001968638,0.0004241481,0.00145639,0.0005618875,0.002614959,0.005323808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006494871,"about_ca_system_score_gemma":0.0008761183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006385524,"about_ca_topic_score_gemma":0.001284353,"domain_scores_codex":[0.9996154,0.00007806199,0.00006974074,0.00005610393,0.0001506855,0.00002988656],"domain_scores_gemma":[0.9993175,0.0002804424,0.0001170772,0.00001582897,0.0001907426,0.00007839499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001316957,0.00008474327,0.0001028257,0.02050746,0.0001114267,0.0001925112,0.00003780096,0.0002335002,0.001107324,0.001539042,0.2620516,0.7139],"study_design_scores_gemma":[0.00002853846,0.00008913886,0.0004570715,0.003354555,0.00008737757,0.0007104204,0.00002446864,0.00004166959,0.0001358213,0.0005348625,0.994526,0.00001024555],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007647738,0.9941218,0.0001004964,0.0008723997,0.00336908,0.0000148597,0.000036958,0.00001383252,0.001394153],"genre_scores_gemma":[0.0005055826,0.9937714,0.0001638398,0.001362899,0.002490386,0.00001923906,0.0000732814,0.000003972598,0.001609516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007281153,"threshold_uncertainty_score":0.02435791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00674600686005434,"score_gpt":0.2736574793723124,"score_spread":0.2669114725122581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}